<?xml version="1.0"?>
<rss version="2.0" xmlns:prism="http://purl.org/rss/1.0/modules/prism/">
  <channel>
    <title>AMA Publishing Group: Neuroendocrinology Topic Collection</title>
    <link>http://pubs.jamanetwork.com/</link>
    <description>
    </description>
    <language>en-us</language>
    <pubDate>Thu, 01 Nov 2012 00:00:00 GMT</pubDate>
    <lastBuildDate>Tue, 01 Jan 2013 00:49:23 GMT</lastBuildDate>
    <generator>Silverchair</generator>
    <managingEditor>editor@pubs.jamanetwork.com</managingEditor>
    <webMaster>webmaster@pubs.jamanetwork.com</webMaster>
    <item>
      <title>Hypothermia, Hypotension, Hypersomnia, and Obesity Associated With Hypothalamic Lesions in a Patient Positive for the Anti–aquaporin 4 Antibody A Case Report and Literature Review  Hypothalamic Lesions and AQP4 Antibody </title>
      <link>http://pubs.jamanetwork.com/article.aspx?articleID=1212193</link>
      <pubDate>Mon, 01 Oct 2012 00:00:00 GMT</pubDate>
      <author>Suzuki K, Nakamura T, Hashimoto K, et al. </author>
      <description>&lt;span class="paragraphSection"&gt;&lt;div class="boxTitle"&gt;Objective&lt;/div&gt;To describe a patient positive for the anti–aquaporin 4 antibody with hypothalamic lesions showing hypothermia, hypotension, hypersomnia, and obesity.&lt;div class="boxTitle"&gt;Design&lt;/div&gt;Case report.&lt;div class="boxTitle"&gt;Setting&lt;/div&gt;University hospital.&lt;div class="boxTitle"&gt;Patient&lt;/div&gt;We describe a 21-year-old woman who was positive for anti–aquaporin 4 antibody and presented with hypothermia, hypotension, and hypersomnia owing to bilateral hypothalamic lesions as the only abnormal clinical finding.&lt;div class="boxTitle"&gt;Results&lt;/div&gt;Immediate steroid administration resulted in significant improvement of the patient's vital signs and imaging findings; however, her cognitive impairment and sleepiness persisted, and she subsequently developed obesity. Decreased cerebrospinal fluid orexin levels and sleep studies confirmed the diagnosis of narcolepsy due to medical condition. Physicians should be aware that neuromyelitis optica spectrum disorders can initially involve the hypothalamus.&lt;div class="boxTitle"&gt;Conclusions&lt;/div&gt;We emphasize that measurement of anti–aquaporin 4 antibody is of clinical importance in the differential diagnosis of hypothalamic lesions.&lt;/span&gt;</description>
      <prism:volume xmlns:prism="prism">69</prism:volume>
      <prism:number xmlns:prism="prism">10</prism:number>
      <prism:startingPage xmlns:prism="prism">1355</prism:startingPage>
      <prism:endingPage xmlns:prism="prism">1359</prism:endingPage>
      <prism:doi xmlns:prism="prism">10.1001/archneurol.2012.300</prism:doi>
      <guid>http://pubs.jamanetwork.com/article.aspx?articleID=1212193</guid>
    </item>
    <item>
      <title> BBS1  Mutations in a Wide Spectrum of Phenotypes Ranging From Nonsyndromic Retinitis Pigmentosa to Bardet-Biedl Syndrome  BBS1  Mutations in a Wide Spectrum of Phenotypes </title>
      <link>http://pubs.jamanetwork.com/article.aspx?articleID=1390044</link>
      <pubDate>Thu, 01 Nov 2012 00:00:00 GMT</pubDate>
      <author>Estrada-Cuzcano A, Koenekoop RK, Senechal A, et al. </author>
      <description>&lt;span class="paragraphSection"&gt;&lt;div class="boxTitle"&gt;Objective&lt;/div&gt;To investigate the involvement of the Bardet-Biedl syndrome (BBS) gene BBS1 p.M390R variant in nonsyndromic autosomal recessive retinitis pigmentosa (RP).&lt;div class="boxTitle"&gt;Methods&lt;/div&gt;Homozygosity mapping of a patient with isolated RP was followed by BBS1 sequence analysis. We performed restriction fragment length polymorphism analysis of the p.M390R allele in 2007 patients with isolated RP or autosomal recessive RP and in 1824 ethnically matched controls. Patients with 2 BBS1 variants underwent extensive clinical and ophthalmologic assessment.&lt;div class="boxTitle"&gt;Results&lt;/div&gt;In an RP proband who did not fulfill the clinical criteria for BBS, we identified a large homozygous region encompassing the BBS1 gene, which carried the p.M390R variant. In addition, this variant was detected homozygously in 10 RP patients and 1 control, compound heterozygously in 3 patients, and heterozygously in 5 patients and 6 controls. The 14 patients with 2 BBS1 variants showed the entire clinical spectrum, from nonsyndromic RP to full-blown BBS. In 8 of 14 patients, visual acuity was significantly reduced. In patients with electroretinographic responses, a rod-cone pattern of photoreceptor degeneration was observed.&lt;div class="boxTitle"&gt;Conclusions&lt;/div&gt;Variants in BBS1 are significantly associated with nonsyndromic autosomal recessive RP and relatively mild forms of BBS. As exemplified in this study by the identification of a homozygous p.M390R variant in a control individual and in unaffected parents of BBS patients in other studies, cis - or trans -acting modifiers may influence the disease phenotype.&lt;div class="boxTitle"&gt;Clinical Relevance&lt;/div&gt;It is important to monitor patients with an early diagnosis of mild BBS phenotypes for possible life-threatening conditions.&lt;/span&gt;</description>
      <prism:volume xmlns:prism="prism">130</prism:volume>
      <prism:number xmlns:prism="prism">11</prism:number>
      <prism:startingPage xmlns:prism="prism">1425</prism:startingPage>
      <prism:endingPage xmlns:prism="prism">1432</prism:endingPage>
      <prism:doi xmlns:prism="prism">10.1001/archophthalmol.2012.2434</prism:doi>
      <guid>http://pubs.jamanetwork.com/article.aspx?articleID=1390044</guid>
    </item>
  </channel>
</rss>